Luca Agnelli
Università degli Studi di Milano
H-index: 49
Europe-Italy
Top articles of Luca Agnelli
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma | Blood Advances | Cristiana Carniti Nicole M Caldarelli Luca Agnelli Tommaso Torelli Silva Ljevar | 2024/4/23 |
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research | Clinical Lung Cancer | Arsela Prelaj Monica Ganzinelli Leonardo Provenzano Laura Mazzeo Giuseppe Viscardi | 2024/3/1 |
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma | Haematologica | Jessica Burroughs Garcia Paola Storti Nicolas Thomas Iannozzi Valentina Marchica Luca Agnelli | 2024/2/2 |
Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study | Clinical Cancer Research | Giovanni Randon Yoshiaki Nakamura Rona Yaeger Sara Lonardi Chiara Cremolini | 2024/1/17 |
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials | Luca Agnelli Andrea Villa Fouziah Butt Matteo Duca Alessandro Guidi | 2024/4/27 | |
A Novel Model Combining Circulating Absolute Monocyte Counts and a Four-Gene Monocyte Signature in Leukapheresis Identifies Lymphoma Patients at Very High Risk of Progression … | Blood | Cristiana Carniti Martina Magni Nicole Caldarelli Tommaso Torelli Luca Agnelli | 2023/11/28 |
P830: IDENTIFICATION OF NOVEL TARGET GENES CORRELATED WITH 1Q21 AMPLIFICATION IN PATIENTS WITH SMOLDERING MYELOMA AND MULTIPLE MYELOMA | HemaSphere | Nicolas Thomas Iannozzi Jessica Burroughs Garcia Paola Storti Denise Toscani Valentina Marchica | 2023/8/1 |
PP01. 01 PEOPLE (NTC03447678), a Phase II Trial to Test Biomarkers of Response to Pembrolizumab as First-Line Treatment in Advanced NSCLC Patients with PD-L1> 50% | Journal of Thoracic Oncology | J Dolezal G Lo Russo C Proto A Prelaj M Ganzinelli | 2023/3/1 |
1901P Specific dynamic changes of peripheral blood immune profile (PBIP) associate with clinical response to nivolumab (NIVO) in patients (pts) with metastatic renal cell … | Annals of Oncology | E Verzoni G Procopio A Bottiglieri M Stellato A Rametta | 2023/10/1 |
A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei | Biomedicines | Shigeki Kusamura Adele Busico Elena Conca Iolanda Capone Luca Agnelli | 2023/7/20 |
Evaluation of clinical benefit and progression-free survival ratio of targeted treatments in a prospective cohort study of patients with biliary tract cancers. | Monica Niger Federico Nichetti Andrea Vingiani Chiara Carlotta Pircher Luca Agnelli | 2023/2/1 | |
2221P Precision oncology in advanced thyroid carcinomas: Impact of molecular tests on patients’ outcomes | Annals of Oncology | E Colombo S Cavalieri E Tamborini F Perrone B Paolini | 2023/10/1 |
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice | Cancer Biomarkers | Andrea Vingiani Daniele Lorenzini Elena Conca Chiara Costanza Volpi Desirè Viola Trupia | 2023/7/18 |
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast … | PLoS Genetics | Lorenzo Ferrando Andrea Vingiani Anna Garuti Claudio Vernieri Antonino Belfiore | 2023/1/3 |
1355P Evaluation of the role of variant allele frequency in EGFR mutated non-small cell lung cancer treated with first line osimertinib | Annals of Oncology | M Brambilla D Lorenzini M Occhipinti S Manglaviti T Beninato | 2023/10/1 |
Molecular tumor board as a clinical tool for converting molecular data into real-world patient care | JCO Precision Oncology | Andrea Vingiani Luca Agnelli Matteo Duca Daniele Lorenzini Silvia Damian | 2023/7 |
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1< 50%: A multiomics analysis | Journal for Immunotherapy of Cancer | Giuseppe Lo Russo Arsela Prelaj James Dolezal Teresa Beninato Luca Agnelli | 2023 |
P-180 PYGO2 is upregulated in multiple myeloma patients with 1q21+: a potential novel therapeutic target | Clinical Lymphoma Myeloma and Leukemia | Jessica Burroughs Garcia Nicolas Thomas Iannozzi Paola Storti Valentina Marchica Valentina Franceschi | 2023/9/1 |
PYGO2-MDR1 Axis in Multiple Myeloma Patients with 1q21 Amplification As Promising Target to Overcome Carfilzomib Resistance | Blood | Nicolas Thomas Iannozzi Jessica Burroughs Garcia Valentina Marchica Valentina Franceschi Denise Toscani | 2023/11/28 |
Prevalence of BRCA homopolymeric indels in an ION torrent-based tumour-to-germline testing workflow in High-Grade ovarian carcinoma | Scientific Reports | Jacopo Azzollini Luca Agnelli Elena Conca Tommaso Torelli Adele Busico | 2023/5/13 |
